| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.391 | 18.574 | 28.710 | 30.432 | 24.926 | 33.981 | 31.512 | 33.584 | 32.293 | 46.424 |
| Total Income - EUR | 12.449 | 18.598 | 29.048 | 31.560 | 25.620 | 34.618 | 31.512 | 33.584 | 32.293 | 46.628 |
| Total Expenses - EUR | 9.129 | 3.449 | 12.959 | 17.254 | 23.280 | 28.742 | 29.681 | 32.629 | 39.819 | 40.479 |
| Gross Profit/Loss - EUR | 3.320 | 15.149 | 16.089 | 14.306 | 2.339 | 5.876 | 1.831 | 955 | -7.527 | 6.148 |
| Net Profit/Loss - EUR | 2.948 | 14.591 | 15.217 | 13.400 | 1.571 | 5.060 | 990 | 202 | -7.818 | 4.777 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gine-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.850 | 22.424 | 20.176 | 25.058 | 26.418 | 22.075 | 40.641 | 35.806 | 24.218 | 11.808 |
| Current Assets | 958 | 19.302 | 1.765 | 4.188 | 1.108 | 7.752 | 69 | 156 | 3.854 | 16.157 |
| Inventories | 223 | 0 | 0 | 3.811 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 204 | 368 | 603 | 0 | 0 | 50 | 0 | 0 | 0 | 502 |
| Cash | 531 | 18.934 | 1.162 | 377 | 1.108 | 7.703 | 69 | 156 | 3.854 | 15.655 |
| Shareholders Funds | -18.624 | -3.843 | 9.869 | 23.088 | 24.211 | 28.812 | 29.163 | 29.456 | 21.549 | 26.205 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 44.432 | 45.569 | 12.073 | 6.159 | 3.315 | 1.015 | 11.547 | 6.507 | 6.523 | 1.759 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gine-Med Srl